Conference series takes pleasure in inviting the scientific community across the globe to attend the 12th European Biosimilars Congress during April 15-16, 2019 at Berlin, Germany with a motto to Explore Innovations in Biosimilars & Biologics. This European Biosimilars Congress 2019 will bring together Professors, scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials, CROs and students from around the world. The passage of biosimilars through a decade at Europe finds much requirement for discussion also focussing the latest developments in the field of biologics and biosimilars.
Kamali Chance, BioSciencesCorp, USA; Cecil Nick, PAREXEL International, UK; David Ebsworth, Vifor Pharma Ltd, Switzerland; Parastoo Azadi, Complex Carbohydrtae Research Center - University of Georgia, USA Fiona M Greer, SGS Life Sciences, Switzerland; András Guttman, SCIEX, USA; Dominic Seitz, Simon-Kucher & Partners, Germany; Rosa Helena Bustos, University of La Sabana, Colombia; Sakae Tsuda, National Institute of Advanced Industrial Science and Technology, Japan; Menachem Zucker, E3D Elcam Drug Delivery Devices, Israel; Victor Tsetlin, Shemyakin Ovchinnikov Institute of Bioorganic Chemistry RAS, Russia; Archana Shubhakar, Ludger Ltd, UK; Kurt R Karst, Hyman, Phelps & McNamara, PC, USA
Euro Biosimilars 2019 Conference will encourage Young Researcher’s Forum, scientists and the researchers in their early stage of career graph to widely discuss their outcome so as to enrich and develop the idea. The ‘Best Poster Award’ is meant to encourage students in taking active part in the International Science platform to sharpen their skills and knowledgebase.